A 73-year-old ex-smoker with chronic obstructive pulmonary disease has FEV₁ 45% predicted and two moderate exacerbations in the past year requiring oral prednisone. He currently uses only salbutamol as needed. He remains dyspnoeic on exertion. According to Canadian Thoracic Society COPD guidance, which change in inhaled therapy is most appropriate?